Quarterly report pursuant to Section 13 or 15(d)

Common Stock and Employee Equity Plans (Tables)

v3.22.2
Common Stock and Employee Equity Plans (Tables) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 25, 2022
Jun. 25, 2022
Jun. 26, 2021
Equity [Abstract]      
Schedule of Common Shares Outstanding  
Common Stock
Shares of common stock outstanding were as follows:
Three Months Ended Six Months Ended
June 25,
2022
June 26,
2021
June 25,
2022
June 26,
2021
(In millions)
Balance, beginning of period 1,620  1,215  1,207  1,211 
Common stock issued for the acquisition of Xilinx —  —  429  — 
Common stock issued under employee equity plans
Common stock repurchases for tax withholding on equity awards (1) —  (1) — 
Issuance of common stock to settle convertible debt —  —  — 
Repurchases of common stock (10) (3) (26) (3)
Balance, end of period 1,612  1,213  1,612  1,213 
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount  
Stock-based Compensation
Stock-based compensation expense was recorded in the Condensed Consolidated Statements of Operations as follows: 
Three Months Ended Six Months Ended
June 25,
2022
June 26,
2021
June 25,
2022
June 26,
2021
(In millions)
Cost of sales $ $ $ 12  $
Research and development 180  53  293  108 
Marketing, general and administrative 104  29  186  58 
Total stock-based compensation expense before income taxes 292  83  491  168 
Income tax benefit (32) (14) (75) (27)
Total stock-based compensation expense after income taxes $ 260  $ 69  $ 416  $ 141 
 
Stock Repurchased During Period, Shares 10,200 25,900  
Payments for Repurchase of Common Stock   $ 2,835 $ 256